Recital 10, Regulation (EU) 2026/314

In forcesince 9 Feb 2026

However, legitimate uses in the production of medicine have been identified for some of the substances concerned, and some commercial laboratories might need to use the other substances as reference standards. Thus, there is a legitimate trade of the nine substances.